Literature DB >> 25247621

Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007.

George Garratty1, Patricia A Arndt2.   

Abstract

This review updates new findings in drug-induced immune- hemolytic anemia (DIIHA) since the 2007 review in Immunohematology by these authors. Twelve additional drugs have been added to the three tables listing drugs associated with drug-dependent antibodies, drugs associated with drug-independent antibodies, and drugs associated with nonimmunologic protein adsorption. Other updated findings include (1) piperacillin is currently the most commonly encountered cause of DIIHA, (2) new data on blood group specificity of drug-dependent antibodies, (3) drug-dependent antibodies detected in healthy donors, (4) DIIHA associated with transplantation, and(5) DIIHA associated with chemotherapeutic drugs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25247621

Source DB:  PubMed          Journal:  Immunohematology        ISSN: 0894-203X


  16 in total

1.  Apomorphine-Induced Immune Hemolytic Anemia.

Authors:  Begoña Venegas Pérez; Teresa Arquero Portero; María Soledad Sánchez Fernández; Cici Feliz Feliz; Javier Del Val Fernández; Pedro José García-Ruiz
Journal:  Mov Disord Clin Pract       Date:  2016-06-06

2.  Piperacillin-induced mild haemolytic anaemia in a 44-year-old patient with cystic fibrosis.

Authors:  Carolin Meinus; Carsten Schwarz; Beate Mayer; J F Roehmel
Journal:  BMJ Case Rep       Date:  2016-10-24

3.  Autologous Blood Transfusion as a Life Saving Measure for a Trauma Patient with Fracture Femur and Drug Induced Hemolytic Anemia: A Case Report.

Authors:  Sumit Vishwakarma; Rahul Chaurasia; Arulselvi Subramanian; Vivek Trikha; Kabita Chatterjee
Journal:  Indian J Hematol Blood Transfus       Date:  2016-08-25       Impact factor: 0.900

4.  Beta-lactam-induced severe neutropenia: a descriptive study.

Authors:  Richard H Aster
Journal:  Fundam Clin Pharmacol       Date:  2019-04       Impact factor: 2.748

Review 5.  Pharmacogenomics with red cells: a model to study protein variants of drug transporter genes.

Authors:  Willy Albert Flegel; Kshitij Srivastava; Tristan Michael Sissung; Barry Ronald Goldspiel; William Douglas Figg
Journal:  Vox Sang       Date:  2020-09-30       Impact factor: 2.996

Review 6.  Clinically and/or Serologically Misleading Findings Surrounding Immune Haemolytic Anaemias.

Authors:  Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-08-10       Impact factor: 3.747

Review 7.  New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia.

Authors:  Wilma Barcellini
Journal:  Transfus Med Hemother       Date:  2015-09-07       Impact factor: 3.747

8.  Mesalazine as a cause of fetal anemia and hydrops fetalis: A case report.

Authors:  Sverker Ek; Staffan Rosenborg
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 9.  Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature.

Authors:  Hans Benno Leicht; Elke Weinig; Beate Mayer; Johannes Viebahn; Andreas Geier; Monika Rau
Journal:  BMC Pharmacol Toxicol       Date:  2018-10-25       Impact factor: 2.483

10.  Hemolytic Anemia and Reactive Thrombocytosis Associated With Cefoperazone/Sulbactam.

Authors:  Ling Zhou; Jianan Bao; Jingjing Ma
Journal:  Front Pharmacol       Date:  2019-11-08       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.